Evidence map›Paper›PMID 39726707›Full record

ArticleFrontiers in oncology2024

Anthony C Johnson, Erdyni N Tsitsikov, Khanh P Phan, Jeffrey A Zuccato, Andrew M Bauer, Christopher S Graffeo, Sanaa Hameed, Tressie M Stephens, Yufeng Liu, Gavin P Dunn and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Anthony C JohnsonDepartment of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Erdyni N TsitsikovDepartment of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Khanh P PhanDepartment of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Jeffrey A ZuccatoDepartment of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Andrew M BauerDepartment of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Christopher S GraffeoDepartment of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Sanaa HameedDepartment of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Tressie M StephensDepartment of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Yufeng LiuDepartment of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Gavin P DunnDepartment of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Alla V TsytsykovaDepartment of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Pamela S JonesDepartment of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Ian F DunnDepartment of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Meningiomas are the most common primary central nervous system (CNS) tumor in adults, comprising one-third of all primary adult CNS tumors. Although several recent publications have identified molecular alterations in meningioma including characteristic mutations, copy number alterations, and gene expression signatures, our understanding of the drivers of meningioma recurrence is limited. Objective: To identify gene expression signatures of 1p Methods: Transcriptomic alterations present in recurrent versus primary 1p Results: Recurrent 1p Conclusions: The

Indexed as

CNS tumorsgene expressionGSTM1meningiomaNF2recurrenttranscriptome profiling

Identifiers

PMID39726707
PMCPMC11669715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.